Wet AMD


For

LASTING VISION IMPROVEMENT

People on EYLEA HD saw an average of 6+ more letters on
an eye chart in a clinical study at 1 year, similar to those on
aflibercept 2 mg.

that may extend the time

between treatments.

After 3 initial monthly treatments, your retina specialist
will choose a treatment schedule of every 2 to 4 months.
Individual results and dosing may vary.

Ask your retina specialist

if

EYLEA HD

is right for you.

IMPORTANT SAFETY INFORMATION

  • EYLEA HD and EYLEA are administered by
    injection into the eye. You should not use
    EYLEA HD or EYLEA if you have an infection
    in or around the eye, eye pain or redness, or
    known allergies to any of the ingredients in
    EYLEA HD or EYLEA, including aflibercept.

  • Injections into the eye with EYLEA HD or
    EYLEA can result in an infection in the eye,
    retinal detachment (separation of retina from
    back of the eye) and, more rarely, serious
    inflammation of blood vessels in the retina
    that may include blockage. Call your doctor
    right away if you experience eye pain or
    redness, light sensitivity, or a change in vision
    after an injection.

  • In some patients, injections with EYLEA HD
    or EYLEA may cause a temporary increase in
    eye pressure within 1 hour of the injection.
    Sustained increases in eye pressure have been
    reported with repeated injections, and your
    doctor may monitor this after each injection.

  • There is a potential but rare risk of serious
    and sometimes fatal side effects, related to
    blood clots, leading to heart attack or stroke
    in patients receiving EYLEA HD or EYLEA.

  • The most common side effects reported in
    patients receiving EYLEA HD were cataract,
    increased redness in the eye, increased
    pressure in the eye, eye discomfort, pain,
    or irritation, blurred vision, vitreous (gel-like
    substance) floaters, vitreous detachment,
    injury to the outer layer of the eye,
    and bleeding in the back of the eye.

  • The most common side effects reported in
    patients receiving EYLEA were increased
    redness in the eye, eye pain, cataract, vitreous
    detachment, vitreous floaters, moving spots
    in the field of vision, and increased pressure
    in the eye.

  • You may experience temporary visual changes
    after an EYLEA HD or EYLEA injection and
    associated eye exams; do not drive or use
    machinery until your vision recovers
    sufficiently.

  • For additional safety information, please talk
    to your doctor and see the full Prescribing
    Information for EYLEA HD and EYLEA.

You are encouraged to report negative side
effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1‑800‑FDA‑1088.

INDICATIONS

EYLEA® HD (aflibercept) Injection 8 mg is a
prescription medicine approved for the treatment
of patients with Wet Age-Related Macular
Degeneration (AMD), Diabetic Macular Edema
(DME), and Diabetic Retinopathy (DR).

EYLEA® (aflibercept) Injection 2 mg is a
prescription medicine approved for the treatment
of patients with Wet Age-Related Macular
Degeneration (AMD), Macular Edema following
Retinal Vein Occlusion (RVO), Diabetic Macular
Edema (DME), and Diabetic Retinopathy (DR).

Please click here for full Prescribing Information for EYLEA HD and EYLEA.

01/2024

US.EHD.23.11.0080